November 22, 2024
Again this year, six Principal Investigators (PIs) from the German Center for Lung Research (DZL) are among the world’s most cited researchers.
Read moreNovember 20, 2024
Researchers at Philipps University Marburg (DZL site UGMLC) have made progress in the management of chronic obstructive pulmonary disease (COPD).
Read moreNovember 19, 2024
A small bite with devastating consequences: Each year, up to 100 million people worldwide contract Dengue fever, with the numbers on the rise.
Read moreNovember 8, 2024
An ATS workshop led by DZL scientist Prof. Mareike Lehmann brings together leading experts to advance precision-cut lung slices (PCLS) as a promising tool for the development of targeted therapies.
Read moreOctober 4, 2024
The German biobanking community met on September 23-24 for the 12th National Biobanking Symposium. Conference president PD Dr. Karoline Gaede, DZL scientist from the Research Center Borstel (ARCN site), welcomed about 200 participants in Berlin.
Read moreSeptember 26, 2024
A healthy lung can recover from small injuries caused by viruses or pollutants. However, this regenerative ability is impaired in patients with pulmonary fibrosis.
Read moreAugust 28, 2024
A recent study published in the scientific journal CHEST, led by DZL scientists from the Institute for Lung Health (ILH) in Gießen, investigated the effectiveness of various risk models for predicting different forms of Pulmonary Hypertension (PH).
Read moreAugust 21, 2024
Lung cancer remains the leading cause of cancer-related deaths in the U.S. and Europe. Despite available treatments, more than 70% of patients experience relapse and eventually succumb to the disease, often due to its spread to other parts of the body.
Read moreAugust 5, 2024
Pulmonary arterial hypertension (PAH) is a rare but serious condition characterized by high blood pressure in the arteries that connect the heart to the lungs. This disease leads to the narrowing and thickening of the arterial walls, which impairs blood flow and increases the pressure in the pulmonary arteries.
Read moreAugust 2, 2024
Lung cancer is the leading cause of cancer deaths worldwide. While early-stage lung cancer can often be treated with radical surgical interventions or chemotherapy, over 70% of patients experience recurrences, primarily due to the spread of the cancer to other parts of the body.
Read moreJuly 24, 2024
A team of researchers at the University of Marburg has discovered a potential biomarker for predicting the course of disease in community-acquired pneumonia.
Read moreJuly 23, 2024
Dupilumab reduces the number of severe exacerbations and improves lung function in COPD patients with type 2 inflammation, according to a study involving DZL scientists.
Read moreJuly 11, 2024
Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time.
Read moreJuly 9, 2024
Arbeitsgruppen aus der Pharmakologie und der Physiologie der Justus-Liebig-Universität Gießen (JLU) veröffentlichen Studie zur Rechtsherzinsuffizienz.
Read moreJuly 4, 2024
Artificial ventilation can save lives but also strains lung tissue. If the lungs are already damaged, pressure ventilation can have undesirable effects. This primarily affects patients with Acute Respiratory Distress Syndrome (ARDS).
Read moreJune 28, 2024
In fall 2022, the Federal Ministry of Education and Research (BMBF) commissioned the Berlin Institute of Health at Charité (BIH) to coordinate the creation of a national strategy for gene- and cell-based therapies.
Read moreJune 10, 2024
From June 5 to 7, 2024, the 12th Annual Meeting of the German Center for Lung Research (DZL) took place at the UGMLC site in Bad Nauheim. The event impressed with a record-breaking attendance of 630 participants and showcased the largest Poster Session in DZL history.
Read moreMay 31, 2024
New therapies for pulmonary hypertension (PH) are the focus of the Giessen Collaborative Research Centre (CRC) 1213. Around 100 million people worldwide are affected by various forms of PH.
Read moreMay 29, 2024
At this year's American Thoracic Society (ATS) congress in San Diego, Prof Werner Seeger, Chairman of the Board and Spokesman of the DZL, received the prestigious Robert F. Grover Award for his life's work in the field of pulmonary hypertension (PH) research.
Read moreMay 27, 2024
Last-resort antibiotics such as polymyxin are used for bacterial infections when conventional antibiotics fail. However, new research findings show that bacteria have an innate mechanism that protects them from polymyxin.
Read moreMore news can be found on the DZL news site. The link below leads to a pre-filtered overview of all UGMLC-related news.
